BRCA1 and breast cancer: Epidemiological data show that TNBC mostly occurs in premenopausal young women under 40 years old and patients harboring a breast cancer susceptibility gene 1 or 2 (BRCA1/2) mutation [4,5], presenting at diagnosis with a larger tumor size, higher grading, and more frequent lymph node spread than other BC subtypes [6,7].